Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 4/2002

01-12-2002 | Case Report

Poorly differentiated oxyphilic (Hürthle cell) carcinoma arising in lingual thyroid: A case report and review of the literature

Authors: Juan Manuel Seoane, MD, PhD, Dr. José Cameselle-Teijeiro, MD, PhD, María Amparo Romero, MD, PhD

Published in: Endocrine Pathology | Issue 4/2002

Login to get access
Metadata
Title
Poorly differentiated oxyphilic (Hürthle cell) carcinoma arising in lingual thyroid: A case report and review of the literature
Authors
Juan Manuel Seoane, MD, PhD
Dr. José Cameselle-Teijeiro, MD, PhD
María Amparo Romero, MD, PhD
Publication date
01-12-2002
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 4/2002
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1385/EP:13:4:353

Other articles of this Issue 4/2002

Endocrine Pathology 4/2002 Go to the issue

Clinical Research

Etiology and significance of the “optically clear nucleus”

Clinical Research

Follicular, papillary, and “Hybrid” carcinomas of the thyroid

Letter To The Editor

Difficult cases of thyroid pathology

Case Report

Problems in differential diagnosis of non-langerhans cell histiocytosis with pituitary involvement: Case report and review of literature

Clinical Research

Loss of heterozygosity mutations to tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis

Clinical Research

Tumors of thyroid follicular epithelium: Where have we been and where are we going?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits